SUBSCRIBE
SUBSCRIBE
News   Deals

French PM Says To Be Vigilant On Drug Industry Moves

October 19, 2005 | 
1 min read

France will be vigilant about ensuring that moves in the pharmaceuticals industry do not hurt its national interests, French Prime Minister Jean-Pierre Raffarin said on Tuesday.

Mergers & acquisitions Europe
Sanofi (France)
MORE ON THIS TOPIC
Digital illustration of human eye color modification and futuristic vision. Made with vector vibrant color gradient geometry form. Isolated on colorful textured background.
Gene therapy
Lilly Doubles Down on Eye Diseases, Adding to BD Spree
November 10, 2025
 · 
1 min read
 · 
Annalee Armstrong
Indianapolis, U.S. - April 16, 2016: Eli Lilly and Company World Headquarters. Lilly makes Medicines and Pharmaceuticals VII
Metabolic disorders
Lilly Makes $1.2B RNAi Pact With SangeneBio, Targets Metabolic Diseases
November 10, 2025
 · 
2 min read
 · 
Tristan Manalac
Differen. A disagreement in business strategy or vision between leaders.
Mergers & acquisitions
Pfizer’s Winning Bid for Metsera Concludes ‘Real Housewives of Biopharma’
November 10, 2025
 · 
3 min read
 · 
Annalee Armstrong
Brussels, Belgium. 21st December 2020. Exterior view of Pfizer Pharmaceutical company's offices.
Mergers & acquisitions
Pfizer Wins Metsera Bidding War Over Novo With Final $10B Price Tag
November 7, 2025
 · 
1 min read
 · 
Dan Samorodnitsky